Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma

Axonal degeneration and death of retinal ganglion cells (RGCs) are the primary causes of vision loss in glaucoma. In this study, we evaluated the efficacy of a peptide (peptain-1) that exhibits robust chaperone and anti-apoptotic activities against RGC loss in two rodent models and in cultured RGCs....

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cell Death Discov
Huvudupphovsmän: Stankowska, Dorota L., Nam, Mi-Hyun, Nahomi, Rooban B., Chaphalkar, Renuka M., Nandi, Sandip K., Fudala, Rafal, Krishnamoorthy, Raghu R., Nagaraj, Ram H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6609721/
https://ncbi.nlm.nih.gov/pubmed/31285855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41420-019-0194-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk